Effect of oral propranolol on benign vascular tumors in children under 15 years
Phase 2
- Conditions
- Cutaneous hemangioma.D18.1?D18.0
- Registration Number
- IRCT2015011920715N1
- Lead Sponsor
- Arak University Of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
age under 15 years; numerous Hemangiomas; tumor size greater than 5 cm; Hemangioma on the face and nose. Exclusion criteria: age over 15 years; underlying heart disease; asthma; liver or kidney dysfunction; hypoglycemia; or low blood pressure due to drug use; consent to continue the study; the presence of compression lesion during the period under consideration.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size and color of blood sugar levels. Timepoint: 3 days, 1 week, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months. Method of measurement: Ultrasound and ruler.
- Secondary Outcome Measures
Name Time Method Recurrent lesions. Timepoint: 6 months after cessation of treatment. Method of measurement: Ultrasound and ruler.